TickerFacts.

Soligenix, Inc. (SNGX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$10.27M
Year ended 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$10.27Mn/a2026-03-31, From 2025-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Soligenix, Inc. (SNGX)2025-12-31-$10.27Mn/a
Earth Science Tech, Inc. (ETST)2026-03-31$1.18M-67.3%
Can-Fite BioPharma Ltd. (CANF)2025-12-31-$8.95Mn/m
FibroBiologics, Inc. (FBLG)2025-12-31-$16.66Mn/m
Nanoviricides, Inc. (NNVC)2025-06-30-$8.54Mn/m
Cocrystal Pharma, Inc. (COCP)2025-12-31-$8.20Mn/m
IGC Pharma, Inc. (IGC)2025-03-31-$4.91Mn/m
GRI Bio, Inc. (GRI)2025-12-31-$10.19Mn/m
CNS Pharmaceuticals, Inc. (CNSP)2025-12-31-$13.83Mn/m

Compare SNGX, ETST, CANF, FBLG side by side · Screen every company in Pharmaceutical Preparations ↗